Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Polyphenon E (EGCg) improves preaged and damaged facial skin

Oct. 28, 2003

Topical bimosiamose studied in psoriasis and atopic dermatitis

Oct. 14, 2003

New topical antiinflammatory agents and their use described by Japan Energy

Oct. 14, 2003

Recombinant alpha1-antitrypsin enters proof-of-concept study for atopic dermatitis

Oct. 13, 2003

Successful completion of phase I trial of Tbeta4

Oct. 10, 2003

Biogen licenses rights to oral psoriasis product from Fumapharm

Oct. 6, 2003

Treatment completed in phase IIb trial of MBI-594AN for acne

Oct. 6, 2003

Positive phase III results for Actiza

Oct. 2, 2003

XMP-629 enters phase I trial for topical treatment of acne

Oct. 2, 2003

Phase II trial of repifermin for chronic venous ulcers does not meet primary endpoint

Sep. 30, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...